BPG is committed to discovery and dissemination of knowledge
This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article
Liu T, Luo X, Li ZH, Wu JC, Luo SZ, Xu MY. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. World J Gastroenterol 2019; 25(36): 5451-5468 [PMID: 31576092 DOI: 10.3748/wjg.v25.i36.5451]

Corresponding Author of This Article
Ming-Yi Xu, PhD, MD, Professor of Medicine, Chief, Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100, Haining Road, Shanghai 200080, China. xumingyi2014@163.com

Research Domain of This Article
Gastroenterology & Hepatology

Article-Type of This Article
Basic Study

Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9836)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2019 (publication date) through Jul 9, 2025
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Cited by in CrossRef
For: | Liu T, Luo X, Li ZH, Wu JC, Luo SZ, Xu MY. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. World J Gastroenterol 2019; 25(36): 5451-5468 [PMID: 31576092 DOI: 10.3748/wjg.v25.i36.5451] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i36/5451.htm |
Number | Citing Articles |
Core Tip